Structure Therapeutics
Tony Peng has a diverse work experience in the pharmaceutical industry. Tony recently joined Structure Therapeutics in September 2021 as the Senior VP, Legal. Prior to that, they worked at Global Blood Therapeutics from November 2017 to September 2021, where they served as the VP, Intellectual Property. Tony Peng also has experience working at Genentech as the Senior Patent Counsel/Patent Counsel from June 2012 to September 2017. Before that, they worked at GSK as both a Senior Patent Counsel/Patent Counsel from June 2005 to June 2012 and a Senior Scientist from June 1999 to June 2005.
Tony Peng completed their education with a Juris Doctor (J.D.) degree from Temple University's James E. Beasley School of Law between 2004 and 2007. Prior to that, they earned a Master's Degree in Computer Science from Villanova University from 2001 to 2003. Furthermore, Tony Peng attained a Master's Degree in Organic Chemistry from Bryn Mawr College from 1997 to 1999.
This person is not in any offices
Structure Therapeutics
Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations inbiologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.